Delivery Order SPE2DX22D0030-SPE2D825F0HT2
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $5,446.79 to AmerisourceBergen Drug Corp on August 29, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp on July 29, 2025, with ultimate completion also set for that date. This firm fixed price delivery order represents a non-competitive award under an existing indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The awardee is a major pharmaceutical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $31,094.70 to AmerisourceBergen Drug Corp on July 26, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order, which received no set-aside designation, represents a competitively awarded contract for pharmaceutical and medical supply procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $12,090 to AmerisourceBergen Drug Corp on July 14, 2025, with a completion date of July 15, 2025. This firm fixed-price contract, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supply fulfillment. The delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, leveraging the company's...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $54,074.37 to AmerisourceBergen Drug Corp on July 28, 2025, with completion expected by July 29, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $5,374.46 to AmerisourceBergen Drug Corp on July 30, 2025, with an ultimate completion date of July 31, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to be performed at the company's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order contract valued at $45,231.48 to AmerisourceBergen Drug Corp on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price, non-set-aside delivery order represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The order will be fulfilled from the vendor's Corporate Office location in Conshohocken, Pennsylvania....
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $16,589.43 to AmerisourceBergen Drug Corp on July 26, 2025, with ultimate completion by July 28, 2025. This firm fixed-price, non-set-aside delivery order represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $77,352.88 to AmerisourceBergen Drug Corp on July 26, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to be delivered to the Place of Performance in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major healthcare...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $136,175.07 to AmerisourceBergen Drug Corp on July 14, 2025, with an ultimate completion date of July 15, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded contract for pharmaceutical and medical supply delivery. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform services at its corporate office...
- SPE2DX22D0030Indefinite Delivery Contract
- SPE2DX22D0030-SPE2D825F0HT2Delivery Order
The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $50,772.76 to AmerisourceBergen Drug Corp on July 3, 2025, with an ultimate completion date of July 7, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under a larger indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider to federal medical procurement programs. The company's primary place of performance for this order is its corporate office location in Conshohocken, PA. This delivery order is issued under AmerisourceBergen Drug Corp's prime indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC functions as a global pharmaceutical support vehicle enabling the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. Through this arrangement, AmerisourceBergen serves multiple federal customers including the Defense Health Agency and U.S. Coast Guard, with the DLA planning to establish additional regional Pharmaceutical Prime Vendor Global Program Generation V contracts to involve multiple contractors in separate geographic areas.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $50.8k | 7/3/25 |